Valeant Tells Full Fed. Circ. Relistor Patent Ruling Is 'Alarming'

By Britain Eakin (June 23, 2020, 8:12 PM EDT) -- Valeant Pharmaceuticals has asked the full Federal Circuit to rehear a panel decision that vacated its win against Mylan Pharmaceuticals in a fight over a patent covering the opioid-induced constipation drug Relistor, saying it can't stand because it "upsets settled law of obviousness."...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!


Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!